Morphologic features of response to Gleevec (Imatinib) treatment of GIST

被引:3
|
作者
Colecchia, M [1 ]
Diment, J [1 ]
机构
[1] Ist Nazl Tumori, I-20133 Milan, Italy
关键词
D O I
10.1177/106689690301100209
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:119 / 119
页数:1
相关论文
共 50 条
  • [41] Pathologic complete response with neoadjuvant imatinib for locally advanced pelvic GIST
    Carla Rameri Alexandre Silva de Azevedo
    Tadeu Ferreira Paiva
    Benedito Mauro Rossi
    Gustavo Cardoso Guimarães
    Maria Dirlei Ferreira de Souza Begnami
    Thiago Bueno Oliveira
    Milton José Barros e Silva
    Marcello Ferretti Fanelli
    Celso Abdon Lopes de Mello
    International Journal of Clinical Oncology, 2011, 16 : 279 - 283
  • [42] Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients
    Schiavon, Gaia
    Ruggiero, Alessandro
    Schoeffski, Patrick
    van der Holt, Bronno
    Bekers, Dave J.
    Eechoute, Karel
    Vandecaveye, Vincent
    Krestin, Gabriel P.
    Verweij, Jaap
    Sleijfer, Stefan
    Mathijssen, Ron H. J.
    PLOS ONE, 2012, 7 (11):
  • [43] RESPONSE OF A PEDIATRIC cKIT GASTROINTESTINAL STROMAL CELL TUMOR (GIST) TO IMATINIB
    Lowenstein, Sarah
    Ganapathi, Shireen
    Reed, Robyn
    Albert, Catherine
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [44] Pathologic complete response with neoadjuvant imatinib for locally advanced pelvic GIST
    Alexandre Silva de Azevedo, Carla Rameri
    Paiva, Tadeu Ferreira, Jr.
    Rossi, Benedito Mauro
    Guimaraes, Gustavo Cardoso
    Ferreira de Souza Begnami, Maria Dirlei
    Oliveira, Thiago Bueno
    Barros e Silva, Milton Jose
    Fanelli, Marcello Ferretti
    Lopes de Mello, Celso Abdon
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (03) : 279 - 283
  • [45] Authors' response: Effect of imatinib mesylate (Gleevec) on anaplastic thyroid carcinoma cell lines
    Podtcheko, A
    Ohtsuru, A
    Namba, H
    Saenko, V
    Yamashita, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10): : 5044 - 5044
  • [46] Potential Role of Imatinib Mesylate (Gleevec, STI-571) in the Treatment of Vestibular Schwannoma
    Altuna, Xabier
    Lopez, Jay Patrick
    Yu, Michael Andrew
    Arandazi, Maria Jesus
    Harris, Jeffrey P.
    Wang-Rodriguez, Jessica
    An, Yi
    Dobrow, Robert
    Doherty, Joni K.
    Ongkeko, Weg M.
    OTOLOGY & NEUROTOLOGY, 2011, 32 (01) : 163 - 170
  • [47] Role of FDG PET in the staging, recurrence and treatment response to imatinib (Glivec) in patients with Gastrointestinal Stromal Tumors (GIST)
    Simo, M
    Garcia, JR
    Soler, M
    Perez, G
    Lopez, S
    Lomena, F
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S335 - S335
  • [48] Sunitinib treatment in pediatric patients with metastatic GIST following failure of imatinib
    Janeway, K.
    Matthews, D.
    Butrynski, J.
    D'Amato, G.
    Agresta, S.
    Garrett, C.
    Corless, C.
    Albritton, K.
    Demetri, G.
    ANNALS OF ONCOLOGY, 2006, 17 : 102 - 102
  • [49] COMBINATION IMATINIB AND BINIMETINIB IS EFFICACIOUS IN TREATMENT-NAIVE ADVANCED GIST
    Chi, P.
    Qin, L. X.
    Nguyen, B.
    Kelly, C. M.
    D'Angelo, S. P.
    Dickson, M. A.
    CANCER DISCOVERY, 2022, 12 (03) : 597 - 597
  • [50] Sunitinib treatment of pediatric metastatic GIST after failure of imatinib.
    Janeway, K. A.
    Matthews, D. C.
    Butrynski, J. E.
    D'Amato, G. Z.
    Agresta, S.
    Garrett, C.
    Corless, C. L.
    Albritton, K. H.
    Demetri, G. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 524S - 524S